Latest Insider Transactions at Sonoma Pharmaceuticals, Inc. (SNOA)
This section provides a real-time view of insider transactions for Sonoma Pharmaceuticals, Inc. (SNOA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sonoma Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sonoma Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2024
|
Poggetto John Dal Controller |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Jun 20
2024
|
Jerome J Dvonch Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,586
+38.78%
|
-
|
|
Jun 20
2024
|
Bruce Thornton Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
53,586
+25.76%
|
-
|
|
Jun 20
2024
|
Amy Moss Trombly Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,586
+25.87%
|
-
|
|
Jun 30
2023
|
Bruce Thornton Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+31.57%
|
-
|
|
Jun 30
2023
|
Amy Moss Trombly Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+31.88%
|
-
|